Atlas Trials

A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment

Clinical trial NCT00537407 · COMPLETED

Trial details

NCT number
NCT00537407
Sponsor
Debiopharm International SA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2007-09-01
Primary completion
2010-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.